Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

response

  • PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors
    You have access
    PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors
    Qaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, Sideris Spyridon, Romain Diamand, Albert Santapau, Alexandre Peltier, Thierry Roumeguère, Patrick Flamen and Carlos Artigas
    Journal of Nuclear Medicine December 1, 2023, 64 (12) 1869-1875; DOI: https://doi.org/10.2967/jnumed.123.265874
  • <sup>68</sup>Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy
    You have access
    68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy
    Qaid Ahmed Shagera, Carlos Artigas, Ioannis Karfis, Gabriela Critchi, Nieves Martinez Chanza, Spyridon Sideris, Alexandre Peltier, Marianne Paesmans, Thierry Gil and Patrick Flamen
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1191-1198; DOI: https://doi.org/10.2967/jnumed.121.263006
  • 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
    You have access
    18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
    Matthias R. Benz, Wesley R. Armstrong, Francesco Ceci, Giulia Polverari, Timothy R. Donahue, Zev A. Wainberg, Andrew Quon, Martin Auerbach, Mark D. Girgis, Ken Herrmann, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 199-204; DOI: https://doi.org/10.2967/jnumed.121.261952
  • Quantitative <sup>68</sup>Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE
    You have access
    Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE
    Claudia Ortega, Rebecca K.S. Wong, Josh Schaefferkoetter, Patrick Veit-Haibach, Sten Myrehaug, Rosalyn Juergens, David Laidley, Reut Anconina, Amy Liu and Ur Metser
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1406-1414; DOI: https://doi.org/10.2967/jnumed.120.256727
  • Open Access
    Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using 18F-Fluorothymidine PET
    Rohini Sharma, Marianna Inglese, Suraiya Dubash, Haonan Lu, David J. Pinato, Chandan Sanghera, Neva Patel, Anthony Chung, Paul D. Tait, Francesco Mauri, William R. Crum, Tara D. Barwick and Eric O. Aboagye
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1743-1748; DOI: https://doi.org/10.2967/jnumed.119.240598
  • You have access
    Breast Cancer Blood Flow and Metabolism on Dual-Acquisition 18F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy Response
    Olivier Humbert, Maud Lasserre, Aurélie Bertaut, Pierre Fumoleau, Charles Coutant, François Brunotte and Alexandre Cochet
    Journal of Nuclear Medicine July 1, 2018, 59 (7) 1035-1041; DOI: https://doi.org/10.2967/jnumed.117.203075
  • You have access
    Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers
    Gary A. Ulaner, Debra A. Goldman, Adriana Corben, Serge K. Lyashchenko, Mithat Gönen, Jason S. Lewis and Maura Dickler
    Journal of Nuclear Medicine July 1, 2017, 58 (7) 1037-1042; DOI: https://doi.org/10.2967/jnumed.116.183335
  • You have access
    Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
    Shozo Okamoto, Anne Thieme, Jakob Allmann, Calogero D’Alessandria, Tobias Maurer, Margitta Retz, Robert Tauber, Matthias M. Heck, Hans-Juergen Wester, Nagara Tamaki, Wolfgang P. Fendler, Ken Herrmann, Christian H. Pfob, Klemens Scheidhauer, Markus Schwaiger, Sibylle Ziegler and Matthias Eiber
    Journal of Nuclear Medicine March 1, 2017, 58 (3) 445-450; DOI: https://doi.org/10.2967/jnumed.116.178483
  • You have access
    Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer
    Marlies Michl, Sebastian Lehner, Philipp M. Paprottka, Harun Ilhan, Peter Bartenstein, Volker Heinemann, Stefan Boeck, Nathalie L. Albert and Wolfgang P. Fendler
    Journal of Nuclear Medicine March 1, 2016, 57 (3) 355-360; DOI: https://doi.org/10.2967/jnumed.115.165613
  • You have access
    15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma
    Keelan Byrne, Shankar Siva, Lori Chait, Jason Callahan, Mathias Bressel, Matthew Seel, Michael P. MacManus and Rodney J. Hicks
    Journal of Nuclear Medicine September 1, 2015, 56 (9) 1328-1333; DOI: https://doi.org/10.2967/jnumed.115.158261

Pages

  • Next
  • 1
  • 2
SNMMI

© 2025 SNMMI

Powered by HighWire